Market closed
Prices delayed by at least 15 minutes | Prices updated on 16 May 2025, 17.40 BST | Print
Haleon PLC (HLN)
ORD GBP0.01Open
404.00p
Previous close
401.60p
Trade high
406.50p
Volume
19,172,213
Year high
417.70p
Year low
319.84p
Dividend yield
1.63%
Market capitalisation
£36.40 bn
Next ex-div date
24/04/2025
P/E ratio
25.73
ISIN
GB00BMX86B70
Next payment date
05/06/2025
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 16/08/2024 | 25/04/2025 |
| Ex-dividend date | 15/08/2024 | 24/04/2025 |
| Payment date | 19/09/2024 | 05/06/2025 |
| Amount | 2.00p | 4.60p |
Company profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of salesfrom global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
News
DIRECTOR DEALINGS: IAG execs sell GBP4 million in shares after results
ALLWEB | Thu, 15/05/2025 - 13:25:44
LONDON BROKER RATINGS: Morgan Stanley raises Haleon; Peel cuts Next
ALLWEB | Fri, 09/05/2025 - 09:09:23
LONDON BROKER RATINGS: Investec starts Oxford Nanopore with 'buy'
ALLWEB | Tue, 06/05/2025 - 08:48:42
LONDON BROKER RATINGS: Citi raises Burberry, Investec cuts Hunting
ALLWEB | Fri, 02/05/2025 - 08:52:36
LONDON BROKER RATINGS: Deutsche Bank, Deutsche Numis raise GlobalData
ALLWEB | Thu, 01/05/2025 - 08:33:34
Haleon first-quarter revenue down slightly amid price promotions
ALLWEB | Wed, 30/04/2025 - 09:53:45
UK dividends calendar - next 7 days
ALLWEB | Thu, 17/04/2025 - 12:23:17
IN BRIEF: Haleon acquires remaining 12% stake in Chinese joint venture
ALLALL | Tue, 15/04/2025 - 10:20:13
LONDON BROKER RATINGS: Morgan Stanley raises Hays to 'equal weight'
ALLWEB | Tue, 08/04/2025 - 08:32:51
Late market roundup: Panic selling grips global equities
ALLAJB | Mon, 07/04/2025 - 16:05:37
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 16/05/2025 | 04:47:01 | 403.909 | 8,562 | 34,582.69 |
| 16/05/2025 | 04:37:03 | 404 | 11,120 | 44,924.80 |
| 16/05/2025 | 04:37:15 | 404 | 53,520 | 216,220.80 |
| 16/05/2025 | 04:36:42 | 404 | 40,140 | 162,165.60 |
| 16/05/2025 | 04:36:12 | 404 | 3,600 | 14,544.00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.